menu
    • menu

    Company profile for Immunome

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunome is developing first-in-class therapeutics to change the way we treat cancer. Our proprietary discovery platform identifies novel therapeutic antibodies, and their targets, by leveraging the “most highly educated” components of the immune systems from patients who have learned to fight off their disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunomeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    665 Stockton Drive, Suite 300 Exton, PA 19341
    Telephone
    Telephone
    610.321.3700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunome.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/immunome-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunome

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204848846/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Immunome To Present At Upcoming Investor Conferences
    Immunome To Present At Upcoming Investor Conferences

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125395767/en/Immunome-to-Present-at-Upcoming-Investor-Conferences

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Immunome Unveils Q3 2025 Financials & Business Update
    Immunome Unveils Q3 2025 Financials & Business Update

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106467522/en/Immunome-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104568267/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Immunome to Present at Guggenheim Health Innovation Conference
    Immunome to Present at Guggenheim Health Innovation Conference

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031809971/en/Immunome-to-Present-at-2nd-Annual-Guggenheim-Healthcare-Innovation-Conference

    BUSINESSWIRE
    31 Oct 2025
    Share Share
    Immunome Reveals HC74 Overcomes ADC Resistance Mechanisms
    Immunome Reveals HC74 Overcomes ADC Resistance Mechanisms

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251023619001/en/Immunome-Presents-Preclinical-Data-Showing-Proprietary-TOP1i-ADC-Payload-HC74-Overcomes-Multiple-Mechanisms-of-ADC-Resistance

    BUSINESSWIRE
    23 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search